PRVA on Nasdaq
Privia Health Group, Inc.
American health services company, incorporated in Delaware. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Oak Street Health, Inc., P3 Health Partners Inc. or LifeStance Health Group, Inc., or pick any stock.
- TickerPRVA on Nasdaq1
- IndustryServices-Health Services1
- HeadquartersArlington, Virginia1
- Incorporated inDE2
- Business address950 N. Glebe Rd., Suite 700, Arlington, Va 222032
- Filer categoryLarge accelerated filer2
See how the biggest companies compare on our leaderboards
Privia Health Group, Inc. (“Privia Health”, “we”, “our”, or the “Company”) is a technology-driven, national physician-enablement company that collaborates with physician practices, health plans, and health systems to achieve the quadruple aim of better outcomes, lower costs, improved patient experience, and happier and more engaged providers. We seek to accomplish the quadruple aim by entering markets and organizing existing physicians and non-physician clinicians into a unique practice model that combines the advantages of a partnership in a large regional medical group (each, a “Medical Group”) with significant provider autonomy for the physicians (collectively, “Privia Physicians”) and non-physician clinicians (collectively “Privia Clinicians” and, together with the Privia Physicians, the “Privia Providers”) in our Medical Groups.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
FFS-Patient Care brought in 64% of the revenue Privia Health Group, Inc. broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2023 | 2024 | 2025 |
|---|---|---|---|
| FFS-Patient Care | $976.7M | $1.1B | $1.4B |
| Capitated Revenue | $338.7M | $213.0M | $308.5M |
| Shared Savings | $170.1M | $179.2M | $234.8M |
| FFS-Administrative Services | $113.2M | $125.4M | $137.0M |
| Care Management Fee (PMPM) | $50.5M | $64.1M | $73.1M |
| Other Revenue | $8.5M | $8.5M | $9.2M |
| Administrative Service | $2.7M | $1.8M | $3.5M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Other costs98¢$2.1B
- Income tax1¢$14.2M
- Profit1¢$22.9M
Out of $2.1B in revenue.4
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$163.4M
Out of $163.4M of cash from operations.4
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $2.1B | $1.7B | $1.7B |
| Provider expense | $1.7B | $1.3B | $1.3B |
| Cost of platform | $252.7M | $227.0M | $197.7M |
| Sales and marketing | $27.1M | $26.4M | $24.7M |
| General and administrative | $138.2M | $126.2M | $109.6M |
| Depreciation and amortization | $9.9M | $7.3M | $6.5M |
| Total operating expenses | $2.1B | $1.7B | $1.6B |
| Operating income | $34.2M | $17.0M | $20.6M |
| Interest income, net | $9.7M | $10.9M | $8.4M |
| Income before provision for income taxes | $43.9M | $27.9M | $29.0M |
| Provision for income taxes | $14.2M | $10.8M | $8.0M |
| Net income | $29.7M | $17.0M | $21.0M |
| Less: Net income (loss) attributable to non-controlling interests | $6.8M | $2.7M | -$2.1M |
| Net income attributable to Privia Health Group, Inc. | $22.9M | $14.4M | $23.1M |
| Net income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share) | $0.19 | $0.12 | $0.20 |
| Net income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share) | $0.18 | $0.11 | $0.19 |
| Weighted average common shares outstanding - basic (in shares) | 122.2M shares | 119.4M shares | 116.7M shares |
| Weighted average common shares outstanding diluted (in shares) | 128.9M shares | 125.6M shares | 124.7M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-02-28 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $479.7M | $491.1M | |||
| Accounts receivable, net of allowance for credit losses of $15.4 million and $9.3 million | $400.9M | $316.2M | |||
| Prepaid expenses and other current assets | $30.4M | $27.5M | |||
| Total current assets | $911.0M | $834.8M | |||
| Property and equipment, net | $504.0K | $1.2M | |||
| Right-of-use assets | $8.8M | $4.8M | |||
| Intangible assets, net | $215.9M | $109.8M | |||
| Goodwill | $209.8M | $141.6M | |||
| Deferred tax asset, net | $2.3M | $26.4M | |||
| Other non-current assets | $21.0M | $17.1M | |||
| Total non-current assets | $458.4M | $301.0M | |||
| Total assets | $1.4B | $1.1B | |||
| Accounts payable and accrued expenses | $96.8M | $82.0M | |||
| Provider liability | $469.5M | $364.6M | |||
| Operating lease liabilities, current | $2.2M | $2.6M | |||
| Total current liabilities | $568.5M | $449.1M | |||
| Operating lease liabilities, non-current | $7.3M | $3.0M | |||
| Other non-current liabilities | $2.6M | $153.0K | |||
| Total non-current liabilities | $9.9M | $3.2M | |||
| Total liabilities | $578.4M | $452.3M | |||
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 123,604,576 and 120,309,346 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $1.2M | $1.2M | |||
| Additional paid-in capital | $892.3M | $813.2M | |||
| Accumulated deficit | -$156.3M | -$179.2M | |||
| Total Privia Health Group, Inc. stockholders equity | $737.2M | $635.2M | |||
| Non-controlling interest | $53.7M | $48.3M | |||
| Total stockholders equity | $790.9M | $683.4M | $607.4M | $519.0M | |
| Total liabilities and stockholders equity | $1.4B | $1.1B | |||
| Accounts receivable, net of allowance for credit losses | $15.4M | $9.3M | |||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 1.0B shares | 1.0B shares | |||
| Common stock, shares issued (in shares) | 123.6M shares | 120.3M shares | |||
| Common stock, shares outstanding (in shares) | 123.6M shares | 120.3M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-02-28 | 2022-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $479.7M | $491.1M | |||
| Accounts receivable, net of allowance for credit losses of $15.4 million and $9.3 million | $400.9M | $316.2M | |||
| Prepaid expenses and other current assets | $30.4M | $27.5M | |||
| Total current assets | $911.0M | $834.8M | |||
| Property and equipment, net | $504.0K | $1.2M | |||
| Right-of-use assets | $8.8M | $4.8M | |||
| Intangible assets, net | $215.9M | $109.8M | |||
| Goodwill | $209.8M | $141.6M | |||
| Deferred tax asset, net | $2.3M | $26.4M | |||
| Other non-current assets | $21.0M | $17.1M | |||
| Total non-current assets | $458.4M | $301.0M | |||
| Total assets | $1.4B | $1.1B | |||
| Accounts payable and accrued expenses | $96.8M | $82.0M | |||
| Provider liability | $469.5M | $364.6M | |||
| Operating lease liabilities, current | $2.2M | $2.6M | |||
| Total current liabilities | $568.5M | $449.1M | |||
| Operating lease liabilities, non-current | $7.3M | $3.0M | |||
| Other non-current liabilities | $2.6M | $153.0K | |||
| Total non-current liabilities | $9.9M | $3.2M | |||
| Total liabilities | $578.4M | $452.3M | |||
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 123,604,576 and 120,309,346 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | $1.2M | $1.2M | |||
| Additional paid-in capital | $892.3M | $813.2M | |||
| Accumulated deficit | -$156.3M | -$179.2M | |||
| Total Privia Health Group, Inc. stockholders equity | $737.2M | $635.2M | |||
| Non-controlling interest | $53.7M | $48.3M | |||
| Total stockholders equity | $790.9M | $683.4M | $607.4M | $519.0M | |
| Total liabilities and stockholders equity | $1.4B | $1.1B | |||
| Accounts receivable, net of allowance for credit losses | $15.4M | $9.3M | |||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 1.0B shares | 1.0B shares | |||
| Common stock, shares issued (in shares) | 123.6M shares | 120.3M shares | |||
| Common stock, shares outstanding (in shares) | 123.6M shares | 120.3M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net income | $29.7M | $17.0M | $21.0M |
| Depreciation | $739.0K | $1.1M | $1.2M |
| Amortization of intangibles | $9.2M | $6.2M | $5.4M |
| Stock-based compensation | $71.1M | $56.7M | $37.1M |
| Deferred income taxes | $10.9M | $8.8M | $7.5M |
| Accounts receivable, net | -$36.7M | -$19.8M | -$96.9M |
| Prepaid expenses and other current assets | -$1.6M | -$9.0M | -$6.2M |
| Other non-current assets and right-of-use assets | -$326.0K | -$1.7M | -$2.4M |
| Accounts payable and accrued expenses | $14.8M | $19.9M | $5.0M |
| Provider liability | $65.6M | $32.9M | $113.4M |
| Operating lease liabilities | -$2.5M | -$2.7M | -$3.2M |
| Other long-term liabilities | $2.4M | -$160.0K | -$1.0M |
| Net cash provided by operating activities | $163.4M | $109.3M | $80.8M |
| Acquisitions, net of cash acquired | -$180.4M | -$7.0M | -$42.9M |
| Other | -$1.2M | -$5.0M | -$113.0K |
| Net cash used in investing activities | -$181.6M | -$12.0M | -$43.0M |
| Repurchase of non-controlling interest | $0 | $0 | -$5.7M |
| Proceeds from non-controlling interest | $0 | $1.7M | $659.0K |
| Distribution to non-controlling interest | -$1.3M | $0 | $0 |
| Proceeds from exercised stock options | $8.0M | $2.7M | $8.7M |
| Net cash provided by financing activities | $6.7M | $4.3M | $3.7M |
| Net (decrease) increase in cash and cash equivalents | -$11.5M | $101.6M | $41.5M |
| Interest paid | $251.0K | $285.0K | $40.0K |
| Income taxes paid, net of refunds | $6.6M | $3.8M | $1.0M |
| Leases liabilities obtained in exchange for right-of-use assets | $6.4M | $0 | $0 |
No quarter-by-quarter statement was filed.
Leadership
Who has led Privia Health Group, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
2025
- Chief executive officerParth Mehrotra Jul 21, 2023 to now11
- PresidentParth Mehrotra Apr 28, 2021 to Jul 5, 202312
- Chief financial officerDavid Mountcastle Apr 28, 2021 to now13
- Chief operating officerParth Mehrotra Apr 28, 2021 to Jul 5, 202312
Board members and other officers (16)
- Board memberFrancis S. Soistman Jr. May 22, 2026 to now14
- Board memberOpella Finley Ernest Sep 3, 2026 to now15
- Board memberLance Berberian Jul 17, 2025 to now16
- Board memberAdam Boehler Jul 10, 2023 to Jun 13, 202417
- Board memberParth Mehrotra Jul 21, 2023 to now11
- Board memberDavid S. Wichmann Aug 3, 2023 to now18
- Board memberPamela O. Kimmet Aug 3, 2023 to now19
- Board memberNancy G. Cocozza Apr 1, 2022 to now20
- Board memberDavid P. King Apr 28, 2021 to now21
- Board memberJeffrey B. Butler Apr 28, 2021 to Nov 15, 202222
- Board memberPatricia Anne Maryland Apr 28, 2021 to now23
- Board memberThomas A. McCarthy Apr 28, 2021 to now24
- Board memberWilliam M. Sullivan Apr 29, 2021 to May 23, 202425
- Board memberJaewon Ryu Jul 1, 2021 to now26
- General counselEdward C. Fargis Jan 31, 2024 to now27
- General counselThomas Bartrum Apr 29, 2021 to Sep 7, 202328
Former names
- PH Group Parent Corp.Feb 13, 2019 to Mar 11, 20202
Timeline
- Jul 21, 2023New chief executive Parth Mehrotra becomes CEO11
Filings
524 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 60 major events, 282 insider forms, 24 large holders, 138 other. The latest 20:
- Oct 7, 2026SCHEDULE 13G/A EDGAR
- Sep 8, 2026SCHEDULE 13D EDGAR
- Sep 3, 20264 EDGAR
- Sep 3, 20263 EDGAR
- Aug 18, 20268-K EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 29, 2026SCHEDULE 13G/A EDGAR
- Jul 13, 20264 EDGAR
- Jul 9, 2026144 EDGAR
- Jul 9, 20264 EDGAR
- Jul 7, 2026144 EDGAR
- Jul 7, 20264 EDGAR
- Jul 7, 20268-K EDGAR
- Jul 7, 20264 EDGAR
- Jul 2, 2026144 EDGAR
- Jul 2, 20264 EDGAR
- Jun 30, 20264 EDGAR
- Jun 30, 20264 EDGAR
- Jun 26, 2026144 EDGAR
The 524 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
261 open-market trades by officers, directors and large owners since October 2021: 7 buys and 254 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 21,275 | $27.67 | $588.7K | Form 4 |
| Jul 7, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 600 | $27.57 | $16.5K | Form 4 |
| Jul 6, 2026 | Morris Matthew ShawnDirector | Sale | 53,722 | $27.24 | $1.5M | Form 4 |
| Jul 2, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 24,734 | $27.50 | $680.2K | Form 4 |
| Jul 2, 2026 | Morris Matthew ShawnDirector | Sale | 59,037 | $27.33 | $1.6M | Form 4 |
| Jul 1, 2026 | Morris Matthew ShawnDirector | Sale | 82,675 | $26.70 | $2.2M | Form 4 |
| Jun 30, 2026 | Morris Matthew ShawnDirector | Sale | 52,823 | $25.72 | $1.4M | Form 4 |
| Jun 29, 2026 | Morris Matthew ShawnDirector | Sale | 63,212 | $25.33 | $1.6M | Form 4 |
| Jun 26, 2026 | Morris Matthew ShawnDirector | Sale | 88,110 | $25.33 | $2.2M | Form 4 |
| Jun 26, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 17,196 | $25.18 | $433.0K | Form 4 |
| May 12, 2026 | Mehrotra ParthChief Executive Officer | Sale | 15,647 | $22.64 | $354.2K | Form 4 |
| May 11, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 3,385 | $22.60 | $76.5K | Form 4 |
| May 11, 2026 | Mehrotra ParthChief Executive Officer | Sale | 105,439 | $22.55 | $2.4M | Form 4 |
| May 4, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 1,206 | $25.00 | $30.1K | Form 4 |
| May 4, 2026 | Morris Matthew ShawnDirector | Sale | 1,017 | $24.96 | $25.4K | Form 4 |
| May 1, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 7,179 | $25.03 | $179.7K | Form 4 |
| May 1, 2026 | Morris Matthew ShawnDirector | Sale | 17,096 | $24.99 | $427.2K | Form 4 |
| Apr 2, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 5,566 | $20.85 | $116.1K | Form 4 |
| Mar 16, 2026 | Mehrotra ParthChief Executive Officer | Sale | 26,509 | $22.11 | $586.1K | Form 4 |
| Mar 16, 2026 | Mountcastle DavidEVP & Chief Financial Officer | Sale | 6,391 | $22.11 | $141.3K | Form 4 |
All 261 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- FMR LLCSCHEDULE 13G/A, 6 filings Jun 12, 2023 to Oct 7, 202629
- Adam BoehlerSCHEDULE 13D, 3 filings Aug 12, 2025 to Sep 8, 202630
- BlackRockSCHEDULE 13G/A, 1 filing Jul 29, 202631
- VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 202632
- VANGUARD GROUP INCSCHEDULE 13G/A, 3 filings Feb 13, 2024 to Mar 27, 202633
- Durable Capital Partners LPSC 13G/A, 2 filings May 15, 2023 to Nov 14, 202434
- Pamplona Capital Partners III, L.P.SC 13G/A, 4 filings Feb 14, 2022 to May 12, 202335
- William M. SullivanSC 13G, 2 filings Apr 5, 2022 to Feb 14, 202336
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| BlackRock, Inc. | 21,402,417 | $550.7M | 0.0% | +2,344,507 |
| Fmr LLC | 12,848,437 | $330.6M | 0.0% | −197,105 |
| Durable Capital Partners LP | 11,635,948 | $299.4M | 2.9% | −451,895 |
| Vanguard Portfolio Management LLC | 6,572,384 | $169.1M | 0.0% | +290,842 |
| Rubicon Founders LLC | 5,971,079 | $153.6M | 78.2% | +22,415 |
| Vanguard Capital Management LLC | 5,156,720 | $132.7M | 0.0% | +147,897 |
| State Street Corp | 4,905,789 | $126.2M | 0.0% | +415,889 |
| Geode Capital Management, LLC | 3,130,473 | $80.6M | 0.0% | +234,939 |
| Riverbridge Partners LLC | 2,998,597 | $77.2M | 2.2% | −919,351 |
| Bank of New York Mellon Corp | 2,892,536 | $74.4M | 0.0% | −50,957 |
| Principal Financial Group Inc | 2,587,878 | $66.6M | 0.0% | −135,195 |
| Dimensional Fund Advisors LP | 2,551,861 | $65.7M | 0.0% | +145,144 |
| Wellington Management Group Llp | 2,130,289 | $54.8M | 0.0% | +1,906,187 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,948,021 | $50.1M | 0.0% | −103,638 |
| BlackBarn Capital Partners LP | 1,585,000 | $40.8M | 10.1% | No change |
| Nuveen, LLC | 1,465,145 | $37.7M | 0.0% | +517,009 |
| Bank Of America Corp /de/ | 1,432,117 | $36.8M | 0.0% | +175,939 |
| Charles Schwab Investment Management Inc | 1,374,828 | $35.4M | 0.0% | +55,722 |
| Goldman Sachs Group Inc | 1,302,019 | $33.5M | 0.0% | −37,931 |
| Northern Trust Corp | 1,253,501 | $32.3M | 0.0% | +75,791 |
| Franklin Resources Inc | 1,228,616 | $31.6M | 0.0% | −250,142 |
| Fort Washington Investment Advisors Inc /oh/ | 1,053,271 | $27.1M | 0.1% | +863,660 |
| Loomis Sayles & Co L P | 1,014,786 | $26.1M | 0.0% | −27,314 |
| Morgan Stanley | 1,005,930 | $25.9M | 0.0% | +24,011 |
| Qube Research & Technologies Ltd | 848,154 | $21.8M | 0.0% | +281,359 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12SEC EDGARParth Mehrotra, President
- 13
- 14
- 15SEC EDGAROpella Finley Ernest, Board member
- 16SEC EDGARLance Berberian, Board member
- 17SEC EDGARAdam Boehler, Board member
- 18SEC EDGARDavid S. Wichmann, Board member
- 19SEC EDGARPamela O. Kimmet, Board member
- 20SEC EDGARNancy G. Cocozza, Board member
- 21SEC EDGARDavid P. King, Board member
- 22SEC EDGARJeffrey B. Butler, Board member
- 23SEC EDGARPatricia Anne Maryland, Board member
- 24SEC EDGARThomas A. McCarthy, Board member
- 25SEC EDGARWilliam M. Sullivan, Board member
- 26SEC EDGARJaewon Ryu, Board member
- 27SEC EDGAREdward C. Fargis, General counsel
- 28SEC EDGARThomas Bartrum, General counsel
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36